Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer

J. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea)

Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Session: Diagnosis, prognostication and treatment of pulmonary embolism
Session type: Thematic Poster
Number: 3122
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea). Rivaroxaban versus low-molecular-weight heparin for venous thromboembolism in gastrointestinal and pancreatobiliary cancer. 3122

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: